Understand Diagnostic Market

Build Diagnostic Plan

Implement Diagnostic Plan

Diagnostic Tracking

New projects launched this month

Landscape analysis for NTRK positive tumor testing
Executed MSA with a Top 10 pharma company
Landscape analysis for breast cancer
IO diagnostic tracking
Lab tracking for AML

What's happening in the industry

FDA clears Thermo Fisher NGS companion diagnostic for three NSCLC treatments read on...

Cancer breakthrough: personalized melanoma vaccines ‘safe and effective’ in first human clinical trials read on...

Genoptix's immuno-oncology testing now covers additional tumor types read on...

Promega intends to seek FDA approval for microsatellite instability assay to assist in strategic cancer decisions read on...

PD-L1 immunohistochemistry in clinical diagnostics of lung cancer: inter-pathologist variability is higher than assay variability read on...

Illumina announces FDA-approved next-generation sequencing cancer companion diagnostic test kit read on...

Read More News

What you might have missed

Listen to our latest webinar - Moving beyond the hype: the reality of NGS in oncology today and in the future
Better Testing Ebook: how testing can play a central role in achieving the optimal economic model
Article: A new disease level precision medicine model - starting with melanoma

Conferences we're attending

Precision Medicine Leaders Summit

21-24 August 2017
San Diego, CA

Meet Us

EU Society Pathology Congress

2-6 September 2017
Amsterdam, The Netherlands

Meet Us


8-12 September 2017
Madrid, Spain

Meet Us